Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating BR1019A and BR1019B combination therapy for essential hypertension and type 2 diabetes mellitus; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• BR1019A
• BR1019B

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Type 2 Diabetes Mellitus | Phase 3 | Status: RECRUITING